Open AccessABO blood groups in COVID‐19 patients; Cross‐sectional study
Author(s) -
Solmaz İhsan,
Araç Songül
Publication year - 2021
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.13927
Subject(s) - abo blood group system , medicine , covid-19 , cross sectional study , disease , gastroenterology , immunology , pathology , infectious disease (medical specialty)
Aim The aim of this study was to investigate the ABO and Rh blood group distribution and clinical characteristics in patients with COVID‐19. Materials and Methods The clinical characteristics and blood groups of 1667 patients who were hospitalised because of COVID‐19 (with a positive PCR test) between 16 March and 10 July were reviewed cross‐sectionally. Results When blood groups of patients diagnosed with COVID‐19 and control group were compared, it was observed that there was an increase in the number of COVID‐19 patients with blood groups A and AB, decrease in the number of COVID‐19 patients with blood group O, a statistically significant increase in the number of individuals with blood group A in COVID‐19 patients compared with healthy individuals, and almost significant increase in the number of COVID‐19 patients with blood group AB and a very significant decrease in the number of COVID‐19 patients with blood group O. Conclusion Our study has found that having blood group O may be protective, that blood group A may have greater susceptibility to the disease, but this does not affect the course of the disease and is not associated with mortality.